Cargando…
Results of a Hepatitis C Micro-Elimination Program in Two Addiction Centers Among Subjects With Substance Use Disorder
OBJECTIVES: We aimed to evaluate a hepatitis C (HCV) micro-elimination program in 2 addiction centers among subjects with substance use disorders (SUD). METHODS: The program was based on simplifying the diagnosis of HCV infections by avoiding referral to primary care for the diagnosis and performing...
Autores principales: | Vega-Astudillo, Pablo, Basurte-Villamor, Ignacio, De Ema López, Inés, Olmos Espinos, Ruth, Mesías-Pérez, Beatriz, Szerman, Nestor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829711/ https://www.ncbi.nlm.nih.gov/pubmed/35153485 http://dx.doi.org/10.1177/11782218221075058 |
Ejemplares similares
-
Gambling Dual Disorder: A Dual Disorder and Clinical Neuroscience Perspective
por: Szerman, Nestor, et al.
Publicado: (2020) -
A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment
por: Basurte-Villamor, Ignacio, et al.
Publicado: (2022) -
Professionals’ perceptions about healthcare resources for co-occuring disorders in Spain
por: Roncero, Carlos, et al.
Publicado: (2014) -
Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study
por: Szerman, Nestor, et al.
Publicado: (2020) -
Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study
por: Szerman, Nestor, et al.
Publicado: (2020)